Posted: 2:56 pm Tue, August 6, 2013
By Daily Record Staff
University of Maryland Ventures, a joint research commercialization effort of the University of Maryland, Baltimore, and the University of Maryland, College Park, announced license and/or option agreements with five life sciences companies across the Baltimore-Washington region.
The companies are Rexahn Pharmaceuticals Inc., of Rockville; IGI Technologies Inc., of Elkridge; Plasmonix Inc., of Arbutus; A&G Pharmaceuticals Inc., ...
Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.